Mydecine Innovations Group Inc. — Proxy Solicitation & Information Statement 2020

Jul 31, 2020

MYDECINE INNOVATIONS GROUP INC.

Security Class : Common Shares

FORM OF PROXY

Annual General Meeting to be held on Friday August 28, 2020

This Form of Proxy is solicited by and on behalf of Management.

Notes to proxy

Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a person or company other than the persons whose names are printed herein, please insert the name of your chosen proxyholder in the space provided (see reverse).

If the securities are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this proxy. If you are voting on behalf of a corporation or another individual you must sign this proxy with signing capacity stated, and you may be required to provide documentation evidencing your power to sign this proxy.

This proxy should be signed in the exact manner as the name(s) appear(s) on the proxy.

If this proxy is not dated, it will be deemed to bear the date on which it is mailed by Management to the holder.

If you appoint the Management Nominees to vote your securities, they will vote in accordance with your instructions or, if no instructions are given, in accordance with the Management Voting Recommendations highlighted for each Resolution overleaf. If you appoint someone else to vote your securities, they will also vote in accordance with your instructions or, if no instructions are given, as they in their discretion choose.

This proxy confers discretionary authority in respect of amendments or variations to matters identified in the Notice of Meeting or other matters that may properly come before the meeting or any adjournment or postponement thereof.

This proxy should be read in conjunction with the accompanying documentation provided by Management.

Proxies submitted must be received by 10:00 am, Pacific Daylight Savings Time, on Wednesday August 26, 2020, or in the case of any adjournment or postponement of the Meeting not less than 48 hours (Saturdays, Sundays and holidays excepted) before the time of the adjourned or postponed meeting.

Proxies submitted must be received by 10:00 am, Pacific Daylight Savings Time, on Wednesday August 26,2020, or in the case of any adjournment or postponement of the Meeting not less than 48 hours (Saturdays,Sundays and holidays excepted) before the time of the adjourned or postponed meeting.	Proxies submitted must be received by 10:00 am, Pacific Daylight Savings Time, on Wednesday August 26,2020, or in the case of any adjournment or postponement of the Meeting not less than 48 hours (Saturdays,Sundays and holidays excepted) before the time of the adjourned or postponed meeting.
VOTING METHODS
MAIL or HAND DELIVERY	National Securities Administrators Ltd.702 – 777 Hornby StreetVancouver, BC V6Z 1S4
FACSIMILE – 24 Hours a Day	604-559-8908
EMAIL	proxy@transferagent.ca
ONLINE	As listed on Form of Proxy or Voter Information Card

If you vote by FAX, EMAIL or On-Line, DO NOT mail back this proxy.

Voting by mail may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual.

Voting by mail, fax or by email are the only methods by which a holder may appoint a person as proxyholder other than the Management nominees named on the reverse of this proxy.

MYDECINE INNOVATIONS GROUP INC.

Appointment of Proxyholder

I/We, being holder(s) of Mydecine Print the name of the person you are Innovations Group Inc. hereby OR appointing if this person is someone other appoint: David Joshua Bartch, CEO, or, than the Management Nominee listed failing him, Erik Knutson, Director. herein.

as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the shareholder in accordance with the following direction (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual General Meeting of shareholders of Mydecine Innovations Group Inc. to be held at Suite 810, 789 West Pender Street, Vancouver, BC on Friday, August 28, 2020 at 10:00 am, Pacific Daylight Savings Time, and at any adjournment or postponement thereof.

VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES.

1. Number of Directors

The number of Directors shall be set to three ( 3 );

For Against □ □

2. Election of Directors

i) DAVID JOSHUA BARTCH

ii) ERIK KNUTSON

iii) MICHAEL A. CONNOLLY

For Withheld

□ □ □ □ □ □

3. Appointment of Auditor

To appoint ADAM SUNG KIM LTD., Chartered Professional Accounts, as auditor of the Company for the ensuing year and to authorize the directors to fix their remuneration;

For Withheld □ □

4. Other Matters

To transact such other business that may be brought properly before the Meeting and any adjournment or postponement of the Meeting.

For Against □ □

Authorized Signature(s) – This section must be Signature(s) completed for your instructions to be executed.

I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby revoke any proxy previously given with respect to the Meeting. If no voting instructions are indicated above, this Proxy will be voted as recommended by Management.

Print Name(s) & Signing Capacity(ies), if applicable

---

Date (MM-DD-YY) THIS PROXY MUST BE DATED

MYDECINE INNOVATIONS GROUP INC.

INTERIM FINANCIAL STATEMENTS

ANNUAL FINANCIAL STATEMENTS

• Mark this box if you would like to receive Interim Financial Statements by mail.

•  Mark this box if you would like to receive Annual Financial Statements by mail.

Financial Statements Request Form

Under securities regulations, a reporting issuer must send annually a form to holders to request the Interim Financial Statements and MD&A and/or the Annual Financial Statements and MD&A. If you would like to receive the report(s) by mail, please make your selection and return to Suite 810 – 789 West Pender Street, Vancouver, British Columbia V6C 1H2.

Alternatively, you may choose to access the report(s) online at www.sedar.com

Mydecine Innovations Group Inc. will use information collected solely for the mailing of such financial statements.

If you wish to receive the financial statements by email, please provide your email address below.

Email Address

• OR -

Please place my name on your financial statement mailing list.

Name

==> picture [416 x 110] intentionally omitted <==

----- Start of picture text ----- Apt. Street Number Street NameCityProv. / State Postal / Zip Code----- End of picture text -----